Edges in Network
Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | SMAD1 |
Upstream (Parents) |
---|
(<<) CASP5 → SMAD1 |
(<<) CASP6 → SMAD1 |
(<<) CDK4 → SMAD1 |
(<<) CENPF → SMAD1 |
(<<) CRLF3 → SMAD1 |
(<<) CSGALNACT2 → SMAD1 |
(<<) CYP1A2 → SMAD1 |
(<<) ERBB2 → SMAD1 |
(<<) GNG10 → SMAD1 |
(<<) HIPK1 → SMAD1 |
(<<) HSPB1 → SMAD1 |
(<<) JAK1 → SMAD1 |
(<<) LIMK2 → SMAD1 |
(<<) MVK → SMAD1 |
(<<) NMNAT1 → SMAD1 |
(<<) PPP3CA → SMAD1 |
(<<) PPP3CC → SMAD1 |
(<<) PRKAB1 → SMAD1 |
(<<) PTGER1 → SMAD1 |
(<<) RHOC → SMAD1 |
(<<) SLMO2 → SMAD1 |
(<<) VAV3 → SMAD1 |
(<<) VPS28 → SMAD1 |
(<<) YWHAE → SMAD1 |
Downstream (Children) |
---|
SMAD1 → ABLIM1 (>>) |
SMAD1 → ALK (>>) |
SMAD1 → BMPR1A (>>) |
SMAD1 → ITPR3 (>>) |
SMAD1 → MAPK13 (>>) |
SMAD1 → NUDT6 (>>) |
SMAD1 → PGF (>>) |